Course Description

Chronic pain affects 100 million Americans. Certain patients with chronic pain are candidates for intrathecal (IT) therapy, which can mitigate some of the risks associated with systemic opioids. Following appropriate patient selection based on medical and psychiatric history and a physical exam, a patient can begin a trial with morphine or ziconotide, the 2 US Food and Drug Administration (FDA)–approved IT therapies. Monitoring for adverse events should continue after IT pump implantation, as should monitoring for catheter- or pump-related complications. This CME/CE-accredited Point of Care 201™ 2-part series discusses identification of candidates for IT therapy, available IT therapies, optimal treatment initiation and management, and both surgical implantation and pump refill techniques.

Realities, Challenges, and Opportunities to Improve Care

This activity is designed to update gastroenterologists, rheumatologists and other specialist clinicians on the latest evidence related to Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in disease pathophysiology and potential implications for future therapeutic strategies. The activity will provide foundational information, relevant across specialties.

Hot Topics in HBV, HCV, and NASH

HIV-Prevention Education for University Student Health Centers

Building Your Understanding to Combat a Growing Problem

Translating Pathophysiology into Targeted Treatments

This CME-accredited four-part CME Snapshot™ series is intended for pulmonologists, allergists, and other specialists involved in the long-term care of patients with severe asthma. In this educational series, expert faculty will review clinical practice guidelines, discuss new approaches to therapy, and hear directly from patients with severe asthma.

Emerging Concepts in Patient Management

Welcome to this RA CME Snapshot™ video series. Each 15-minute module offers focused, clinically actionable education for rheumatologists and other clinicians who manage patients with RA. For a comprehensive curriculum on current evidence-based guidelines and newly published data on the use of targeted inhibitors of interleukin (IL)-6 or Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathways, clinicians can complete all 6 video modules for a total of 1.5 AMA PRA Category 1 Credits™ or 1.5 hours of nursing contact hours.

Key Issues Impacting OB/GYN Practice

Looking Beyond Barriers to Optimize Therapy

Evolving Models of HIV Care (Volume 1) - Rapid ART Initiation: A New Addition to the HIV-Care Tool Box

Building Bridges to Reach People Who Inject Drugs with the Goal to Eliminate HCV

Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships

An Interactive Experience Highlighting Recent Clinical Advances

This accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein cholesterol (LDL-C) levels using nonstatin lipid-lowering medications, including inhibitors of the enzyme protein convertase subtilisin/kexin type 9 (PCSK9).

Integrating PCSK9 Inhibitors Into Hypercholesterolemia Management

Discussions and Debates on the Evolving Roles of Targeted Synthetic DMARDs

Moving From Disease Pathophysiology to Mechanism-Based Therapies